Local Coverage Determination (LCD): Varicose Veins of the Lower Extremities (L31796)



Similar documents
Medicare C/D Medical Coverage Policy

Medicare C/D Medical Coverage Policy

MEDICAL COVERAGE POLICY. SERVICE: Varicose Veins of the Lower Extremities. PRIOR AUTHORIZATION: Required.

PROVIDER POLICIES & PROCEDURES

Yes when meets criteria below

MEDICAL COVERAGE POLICY SERVICE: Varicose Veins of the Lower Extremities. SERVICE: Treatment of Varicose Veins of the Lower Extremities

Clinical Review Criteria

Clinical Medical Policy Varicose Vein Treatment

Medical Coverage Policy Treatment for Varicose Veins-PREAUTH

Effective Date: March 2, 2016

Venous Reflux Disease and Current Treatments VN20-87-A 01/06

Surgical Options for Venous Disease. Sandra C Carr MD Vascular Surgery Meriter Wisconsin Heart

Medical Coverage Policy Varicose Vein Treatment sad

Non-surgical treatment of severe varicose veins

Local Coverage Article: Venipuncture Necessitating Physician s Skill for Specimen Collection Supplemental Instructions Article (A50852)

Local Coverage Determination (LCD): Non- Emergency Ground Ambulance Services (L33383)

Spotlight Series: Interventional Radiology. Varicose Veins and Venous Insufficiency

Local Coverage Determination (LCD): MolDX: Breast Cancer Assay: Prosigna (L36125)

Contractor Number Oversight Region Region IV

Contractor Information. LCD Information. Local Coverage Determination (LCD): HbA1c (L32939) Contract Number 11202

Patient Information Understanding Varicose Veins

LCD L C-Reactive Protein High Sensitivity Testing (hscrp)

Varicose Veins: Causes, Symptoms and Management. Andrew C. Stanley MD Section of Vascular Surgery

Medical Affairs Policy

treatment of varicose and spider veins patient information SAMPLE a publication by advancing vein care

Local Coverage Determination (LCD): Medicine: Autonomic Function Tests (L34500)

Modern Varicose Vein Treatments: What Every Patient Should Know

Corporate Medical Policy Treatment of Varicose Veins/Venous Insufficiency. Medical Policy

Local Coverage Determination (LCD): Screening and Diagnostic Mammography (L29328)

X-Plain Varicose Veins Reference Summary

Peninsula Commissioning Priorities Group. Commissioning Policy Varicose Vein Referral

LOWER EXTREMITY VENOUS DUPLEX ULTRASOUND:

Modern Management of Varicose Veins

Local Coverage Determination (LCD): Vitamin B 12 Injection (L33502)

Microfoam Ultrasound-Guided Sclerotherapy of Varicose Veins in 100 Legs

TREATMENT OF VARICOSE VEINS: CAN IT BE IMPROVED BY MECHANOCHEMICAL ABLATION USING THE CLARIVEIN DEVICE?

The Treatment of Varicose Veins and Spider Veins

Treatment by LASER. Understanding Varicose veins and. Dr. Rajesh Mundhada (MD. DNB) Dr. Atul Rewatkar (MD)

CHAPTER 15 SCLEROTHERAPY FOR VENOUS DISEASE

VARICOSE VEINS. Information Leaflet. Your Health. Our Priority. VTE Ambulatory Clinic Stepping Hill Hospital

THE VEIN CENTER. State-of-the-Art Treatment for Varicose Veins and Spider Veins

Recurrent Varicose Veins. Vineet Mishra, MD Director of Mohs Surgery and Procedural Dermatology University of Texas Health Science Center San Antonio

RANDOMIZED CONTROL TRIALS (RCT s) on VARICOSE VEIN ENDOVENOUS TREATMENT

Global Surgery Fact Sheet

Local Coverage Article: Cardiovascular Stress Testing (A53123)

Beaumont Hospital. Varicose Veins. and their TREATMENT. Professor Austin Leahy, MCh, FRCS, FRCSI

TREATMENT OF VARICOSE AND SPIDER VEINS Patient Info

SEDICO Newsletter Issue 8. Varicose veins

Varicose veins are generally identified

Health Technology Assessment of Scheduled Surgical Procedures

DEBATE ON Management of primary Varicose Veins SURGERY. Adel Husseiny, Kamhawy Vascular Surgery Unit Tanta University

Varicose Vein Treatment (Endovenous Ablation of Varicose Veins)

Emory Healthcare s model for a PA based vein clinic

CHINOOK VASCULAR - ENDOVENOUS LASER ABLATION PROCEDURE

Suffering from varicose veins? Patient Information. ELVeS Radial Minimally invasive laser therapy of venous insufficiency

Dr Marc Vuylsteke Sint-Andriesziekenhuis Tielt Belgium

CMS National Coverage Policy

Varicose veins - 1 -

Recurrent Varicose Veins

Local Coverage Determination (LCD): Surgical Treatment of Nails (L33833)

Varicose Veins and Spider Veins

Local Coverage Article: Endovascular Repair of Aortic Aneurysms (A53124)

Local Coverage Determination (LCD): Spinal Cord Stimulation (Dorsal Column Stimulation) (L34705)

Endovenous Laser Therapy

VARICOSE VEINS AND VENOUS INSUFFICIENCY

Varicose Vein Therapy: An Introduction to Surgical and Endovascular Treatment

Endovenous Treatment of Varicose Veins

Provided by the American Venous Forum: veinforum.org

Local Coverage Determination (LCD) for Surgery: Trigger Point Injections (L30066)

LONG TERM FOLLOW-UP AFTER ENDOVENOUS LASER ABLATION

Spider and Varicose Veins

Billing and Coding Guidance Co-morbidities associated with morbid obesity

Prevalence and surgical outcomes of varicose veins at Regional Institute of Medical Sciences, Imphal

Status Active. Assistant Surgeons. This policy addresses reimbursement for assistant surgical procedures during the same operative session.

Local Coverage Determination (LCD) for Trigger Point Injections (L28310)

POLICY PRODUCT VARIATIONS DESCRIPTION/BACKGROUND RATIONALE DEFINITIONS BENEFIT VARIATIONS DISCLAIMER CODING INFORMATION REFERENCES POLICY HISTORY

Treatment of Varicose Veins/Venous Insufficiency

Dr. Linde is an international beauty expert and an acclaimed keynote speaker at conferences all over the world. He is specialized in the treatment of

EndoVenous Laser Therapy (EVLT) Information Booklet. Dr. Dueck. Varicose Veins

Treatment of Varicose Veins

ENTITLEMENT ELIGIBILITY GUIDELINES VARICOSE VEINS AND SUPERFICIAL THROMBOPHLEBITIS

Removal of Benign and Malignant Skin Lesions (DRAFT POLICY)

Varicose Veins Operation. Patient information Leaflet

V03 Varicose Veins Surgery

Varicose veins and spider veins

HEALTH DEPARTMENT BILLING GUIDELINES

Local Coverage Determination (LCD): E&M Home and Domiciliary Visits (L33817)

Suppliers are to follow The Health Plan requirements for precertification, as applicable.

Endovenous Laser: A New Minimally Invasive Method of Treatment for Varicose Veins - Preliminary Observations Using an 810 nm Diode Laser

this period, elimination of saphenous vein reflux was accomplished surgically (ie, with ligation and stripping)

Transcription:

Local Coverage Determination (LCD): Varicose Veins of the Lower Extremities (L31796) Contractor Information Contractor Name Palmetto GBA LCD Information Document Information LCD ID L31796 LCD Title Varicose Veins of the Lower Extremities AMA CPT / ADA CDT / AHA NUBC Copyright Statement CPT only copyright 2002-2014 American Medical Association. All Rights Reserved. CPT is a registered trademark of the American Medical Association. Applicable FARS/DFARS Apply to Government Use. Fee schedules, relative value units, conversion factors and/or related components are not assigned by the AMA, are not part of CPT, and the AMA is not recommending their use. The AMA does not directly or indirectly practice medicine or dispense medical services. The AMA assumes no liability for data contained or not contained herein. The Code on Dental Procedures and Nomenclature (Code) is published in Current Dental Terminology (CDT). Copyright American Dental Association. All rights reserved. CDT and CDT-2010 are trademarks Original Effective Date For services performed on or after 03/19/2011 Revision Effective Date For services performed on or after 09/11/2014 Revision Ending Date Retirement Date Notice Period Start Date Notice Period End Date

of the American Dental Association. UB-04 Manual. OFFICIAL UB-04 DATA SPECIFICATIONS MANUAL, 2014, is copyrighted by American Hospital Association ( AHA ), Chicago, Illinois. No portion of OFFICIAL UB-04 MANUAL may be reproduced, sorted in a retrieval system, or transmitted, in any form or by any means, electronic, mechanical, photocopying, recording or otherwise, without prior express, written consent of AHA. Health Forum reserves the right to change the copyright notice from time to time upon written notice to Company. CMS National Coverage Policy Title XVIII of the Social Security Act, 1862(a)(1)(A), (a)(7), excludes expenses incurred for items or services which are not reasonable and necessary for the diagnosis or treatment of illness or injury or to improve the functioning of a malformed body member; routine physical checkups, screening. Title XVIII of the Social Security Act, 1833(e); prohibits Medicare payment for any claim which lacks the necessary information to process the claim. 42 CFR 411.15(k)(1); reasonable and necessary for diagnoses and treatment of illness or injury or to improve the functioning of a malformed body member. CMS Manual System, Pub 100-08, Medicare Program Integrity Manual, Chapter 3, 3.4.1.3; Diagnosis Code Requirements. Coverage Guidance Coverage Indications, Limitations, and/or Medical Necessity The treatment of varicose veins of the lower extremities is considered medically necessary when the following criteria are met prior to the decision for treatment: 1. A minimum 3-month trial of conservative therapy with graduated elasticized compression stockings has failed or was not feasible. 2. The patient is symptomatic and the varicosities result in any one or more of the following in spite of conservative therapy: Persistent symptoms interfering with activities of daily living such as aching, cramping, burning, pain, itching and/or swelling during activity or after prolonged standing.

Significant, recurrent superficial phlebitis. Hemorrhage from a ruptured varix. Non-healing skin ulceration of the lower extremity. 3. Duplex studies of the venous system are performed by an accredited vascular technician that fully defines the anatomy, size, and tortuosity of the greater and lesser saphenous vein, superficial venous segments and perforators. Studies must demonstrate the following criteria: Absence of deep venous thrombosis, and Greater saphenous vein valvular incompetence/reflux that correlates with the patient s symptoms. 4. In addition, the following conditions apply to specific individual procedures: Injection/Compression Sclerotherapy 1. No saphenofemoral insufficiency, incompetence, or occlusion of the deep venous system, and 2. Vessel diameter should be at least 3 millimeters in size. Surgical Ligation or Stripping: 1. May be covered as part of a combination procedure with sclerotherapy. 2. Number of veins and their locations should be documented. Endoluminal Radiofrequency Ablation (ERFA) or Laser Ablation 1. Patient s anatomy amenable to laser or radiofrequency catheter. 2. Non-aneurismal saphenous vein(s). 3. Absence of vein tortuosity that would impair catheter advancement. Ambulatory or Stab Phlebectomy 1. Use of 2mm stab incisions to remove vein via crochet type hook. 2. May be covered only when the patient displays symptoms and functional problems attributable only to the secondary, smaller vessels. 3. Not covered on the same date of service as another vein procedure, such as ERFA.

Subfascial Endoscopic Perforator Surgery (SEPS) 1. Must have symptoms of perforator incompetence. 2. Must have a venous stasis ulcer in which a history of conservative measures failed. LIMITATIONS Noncompressive sclerotherapy implies injection of the sclerosant into veins when the patient is upright and the veins are full. Technically, this is thrombotic therapy, not sclerotherapy. This method has not been shown effective in producing long-term obliteration of the incompetent veins and is not covered. The treatment of spider veins or superficial telangiectasis by any technique is considered cosmetic, and therefore not covered, unless there is associated significant and persistent bleeding. Laser treatment of superficial varicosities or spider veins is considered cosmetic and is not covered. Ultrasound-monitored or duplex-guided techniques for sclerotherapy will not be covered when used in conjunction with injection sclerotherapy techniques. Pre-operative venous studies will be covered when initially performed to determine the extent of venous valvular incompetence. Additional reimbursement is not available for these or other radiologically guided or monitoring techniques when performed solely to guide the needle or introduce the sclerosant into the varicose vein. Symptomatic improvement is the primary goal and indicator of a satisfactory outcome. Documentation of recanalization or failure of vein closure without recurrent signs and symptoms does not necessarily indicate a need for additional treatments. Coding Information Bill Type Codes: Contractors may specify Bill Types to help providers identify those Bill Types typically used to report this service. Absence of a Bill Type does not guarantee that the policy does not apply to that Bill Type. Complete absence of all Bill Types indicates that coverage is not influenced by Bill Type and the policy should be assumed to apply equally to all claims.

Revenue Codes: Contractors may specify Revenue Codes to help providers identify those Revenue Codes typically used to report this service. In most instances Revenue Codes are purely advisory; unless specified in the policy services reported under other Revenue Codes are equally subject to this coverage determination. Complete absence of all Revenue Codes indicates that coverage is not influenced by Revenue Code and the policy should be assumed to apply equally to all Revenue Codes. 99999 Not Applicable CPT/HCPCS Codes Group 1 Paragraph: CPT CODES Group 1 Codes: 36470 Injection therapy of vein 36471 Injection therapy of veins 36475 Endovenous rf 1st vein 36476 Endovenous rf vein add-on 36478 Endovenous laser 1st vein 36479 Endovenous laser vein addon 37500 Endoscopy ligate perf veins 37700 Revise leg vein 37718 Ligate/strip short leg vein 37722 Ligate/strip long leg vein 37761 Ligate leg veins open 37765 Stab phleb veins xtr 10-20 37766 Phleb veins - extrem 20+ 37780 Revision of leg vein 37785 Ligate/divide/excise vein ICD-9 Codes that Support Medical Necessity Group 1 Paragraph: Use of these codes does not guarantee reimbursement. The patient s medical record must document that the coverage criteria in this policy have been met. Group 1 Codes: 454.0 VARICOSE VEINS OF LOWER EXTREMITIES WITH ULCER

454.1 VARICOSE VEINS OF LOWER EXTREMITIES WITH INFLAMMATION VARICOSE VEINS OF LOWER EXTREMITIES WITH ULCER AND 454.2 INFLAMMATION 454.8 VARICOSE VEINS OF LOWER EXTREMITIES WITH OTHER COMPLICATIONS 459.31 CHRONIC VENOUS HYPERTENSION WITH ULCER 459.33 CHRONIC VENOUS HYPERTENSION WITH ULCER AND INFLAMMATION ICD-9 Codes that DO NOT Support Medical Necessity Paragraph: All other ICD-9 codes not listed under "ICD-9 Codes that Support Medical Necessity" will be denied as not medically necessary. General Information Associated Information Documentation Requirements Documentation supporting the medical necessity should be legible, maintained in the patient's medical record for each date of service billed, and must be made available to the A/B MAC upon request. For all varicose vein treatment modalities discussed in this policy, the patient s operative report, medical treatment history, and progress notes documenting patient compliance with prescribed conservative treatment must clearly indicate that all initial and procedural coverage criteria are met as outlined under the Indications section of this policy. Medical record documentation must specifically state the vessel(s) and perforator(s) treated for each procedure, as well as the vessel diameter. If additional procedures are performed on the same vessel(s) at a future date, documentation must show a recurrence of signs and symptoms, which are specifically caused by that vessel. Otherwise, the procedure will be considered cosmetic. Utilization Guidelines Services performed for excessive frequency are not medically necessary. Frequency is considered excessive when services are performed more frequently than generally accepted by peers and the reason for additional services is not justified by documentation.

Sources of Information and Basis for Decision 1. Bergan JJ, Kumins NH, Owens EL, et al. Surgical and Endovascular Treatment of Lower Extremity Venous Insufficiency. J Vasc Interv Radiol. 2002;13(6):563-8. 2. Ballard JL, Rulli F, Carcia-Rinaldi R, et al. Subfascial Endoscopic Perforator Vein Surgery Combined with Saphenous Vein Ablation: Results and Critical Analysis. J Vasc Surg. 2003;38(5):1139. 3. Goldman MP, Amiry S. Closure of the Greater Saphenous Vein with Endoluminal Radiofrequency Thermal Heating of the Vein Wall in Combination with Ambulatory Phlebectomy: 50 Patients with More than 6-Month Follow-Up. Dermatol Surg. 2002;28(1):29-31 4. Goldman MP, Weiss RA, Bergan JJ. Diagnosis and Treatment of Varicose Veins: A Review. J Am Acad Dermatol. 1994;31(3 Pt 1):393-413. 5. Goldman MP. Treatment Of Varicose And Telangiectatic Leg Veins: Double-Blind Prospective Comparative Trial Between Aethoxyskerol And Sotradecol. Dermatol Surg. 2002;28(1):52-5. 6. Merchant RF, DePalma RG, Kabnick LS. Endovascular Obliteration of Saphenous Reflux: A Multicenter Study. J Vasc Surg. 2002;35(6):1190-6. 7. Min RJ, Khilnani N, Zimmet SE. Endovenous Laser Treatment of Saphenous Vein Reflux: Long Term Results. J Vasc Interv Radiol. 2003;14:991-6. 8. TenBrook JA, Jr, Iafrati MD, O'donnell TF, Jr, et al. Systematic Review of Outcomes After Surgical Management of Venous Disease Incorporating Subfascial Endoscopic Perforator Surgery. J Vasc Surg. 2004;39(3):583-9. 9. Weiss RA, Weiss MA. Controlled Radiofrequency Endovenous Occlusion Using a Unique Radiofrequency Catheter Under Duplex Guidance to Eliminate Saphenous Varicose Vein Reflux: A 2-Year Follow-Up. Dermatol Surg. 2002;28(1):38-42 Revision History Information Please note: Most Revision History entries effective on or before 01/24/2013 display with a Revision History Number of "R1" at the bottom of this table. However, there may be LCDs where these entries will display as a separate and distinct row. Revision History Date Revision History Number Revision History Explanation Reason(s) for Change

09/11/2014 R3 11/14/2013 R2 10/18/2012 R1 Under Sources of Information and Basis for Decision removed the verbiage "The development and coverage guidelines in this policy were based on a review of pertinent medical literature, policies from other Medicare contractors, and discussions with appropriate specialists," as this section is for bibliographies used to develop the LCD. Corrected the authors names in #s 2 removed Bianchi C and Abou- Zamom AM and replaced with Rulli F, and Garcia-Rinaldi R,#5 removed authors names Peterson JD, Weiss RA and et al. Under CMS National Coverage Policy added the following reference citations: 42 CFR 411.15 (k)(1); Reasonable and necessary for diagnoses and treatment of illness or injury. CMS On-Line Manual, Publication 100-08, Chapter 3, Section 3.4.1.3, Diagnosis Code Requirements. Under Sources of Information and Basis for Decision added additional authors to the various articles and put bibliographies in AMA format. Annual review and validation completed. Revision #4, 10/18/2012 Under CMS National Coverage Policy added Social Security Act Title XVIII publications; 1862 (a)10, 1862 (a)(1)a, 1862 (a)(7) and 1833 (e). Under ICD-9 CM Codes That Support Medical Necessity ICD-9 codes 459.31, 459.33 were added. Under Documentation Requirements the verbiage "All documentation must be available upon request by Medicare" was replaced with "Documentation supporting the medical necessity should be legible, maintained in the patient's medical record for each date of service billed, and must be made available to the A/B MAC upon request." This revision becomes effective on 10/18/2012. Provider Education/Guidance Public Education/Guidance Provider Education/Guidance Other (Reviewed bibliography, adding authors names and putting in AMA citation format style.)

3 06/18/2011 Revision Effective Date: Services performed on or after 06/18/2011 Per scheduled J11 implementation, LCD added to South Carolina #11202 and West Virginia #11402. 2 05/28/2011 Revision Effective Date: Services performed on or after 05/28/2011 Per scheduled J11 implementation, LCD added to North Carolina MAC# 11502. 1 3/19/2011 Effective Date: 3/19/2011 In accordance with the Medicare Modernization Act of 2003, LCD# L1389 from Carrier# 00880 has been selected for the J11 implementation. Associated Documents Attachments Related Local Coverage Documents Related National Coverage Documents Public Version(s) Updated on 09/04/2014 with effective dates 09/11/2014 - Updated on 11/08/2013 with effective dates 11/14/2013-09/10/2014